BackDuoGenic StemCells corporation Overview

DuoGenic StemCells corporation Total Liabilities

Latest total liabilities for 7607.TWO: $35M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$35.30M
↓ 10.07% YoYΔ $-3.95M vs prior year quarter

Peer trimmed avg / median

Loading

DuoGenic StemCells corporation Total Liabilities History

Loading

DuoGenic StemCells corporation vs. peers: Total Liabilities Comparison

Loading

DuoGenic StemCells corporation Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DuoGenic StemCells corporation (7607.TWO) FAQ

DuoGenic StemCells corporation (7607.TWO) currently reports a total liabilities of $35M as of June 2026. That compares with $39M in the prior-year period — down 10.1% year over year. Use the charts on this page to explore DuoGenic StemCells corporation's total liabilities history and peer comparisons.

DuoGenic StemCells corporation's total liabilities decreased from $39M to $35M — a 10.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DuoGenic StemCells corporation reported $35M in total liabilities as of June 2026. That compares with $39M in the prior-year period — down 10.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DuoGenic StemCells corporation, and consider following 7607.TWO for alerts when major investors trade the stock.